SGLT2-IN-4
SGLT2-IN-4 (Compound 1) is a selective and orally active sodium-dependent glucose cotransporter-2 (SGLT2) inhibitor. SGLT2-IN-4 can increase the proportion of protein α-helix and enhance the stability of the SGLT2-D201A mutant. SGLT2-IN-4 can be used for the research of type 2 diabetes[1].
Product Specifications
UNSPSC
12352005
Target
SGLT
Related Pathways
Membrane Transporter/Ion Channel
Field of Research
Metabolic Disease
Smiles
[H][C@@]1(O[C@H]([C@@H]([C@H]([C@@H]1O)O)O)CO)C2=C(C=C(C(CC3=CC=C(C=C3)OCC)=C2)Cl)CCOCCO
Molecular Formula
C25H33ClO8
Molecular Weight
496.98
References & Citations
[1]Haque A, et al. Identification of New Small-Molecule SGLT2 Inhibitors: In-Silico Approach to Therapeutics for Diabetes-Related Complications[J]. ACS Omega, 2025.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
SGLT2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
040518-ML405 100 µL
PRSS16, NT (PRSS16, TSSP, Thymus-specific serine protease, Serine protease 16) (MaxLight 405) discontinued
Ask
View Details 
bs-5527R-BF555 100 µL
Phospho-NPTX1 (Tyr344) Polyclonal Antibody, AbBy Fluor™ 555 Conjugated
Ask
View Details MBS9001458 Inquire
Rabbit anti-Oryza sativa subsp. japonica (Rice) LOGL10 Polyclonal Antibody
Ask
View Details